Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of BIIB094 in adults with Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIIB094

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED